Associations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older women

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 2, 2014, Pages 350-355

  Tillmans, Lori S ^a   Vierkant, Robert A ^b   Wang, Alice H ^b   Samadder, N Jewel ^f   Lynch, Charles F ^g   Anderson, Kristin E ^e   French, Amy J ^a   Haile, Robert W ^h   Harnack, Lisa J ^e   Potter, John D ⁱ   Slager, Susan L ^b   Smyrk, Thomas C ^a   Thibodeau, Stephen N ^a   Cerhan, James R ^c   Limburg, Paul J ^d  

^a Departments of Pathology and Laboratory Medicine   (United States)

^b Departments of Internal Medicine Pulmonary and Critical Care Medicine   (United States)

^c Division of Epidemiology   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SMOKING; AGE; BIOSYNTHESIS; COHORT ANALYSIS; COLORECTAL NEOPLASMS; EPIDEMIOLOGY; ESTROGEN THERAPY; GENETICS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK FACTOR; UNITED STATES;

AGE FACTORS; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLIC ACID; HUMANS; IOWA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84893636906     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0780     Document Type: Article

References (26)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010;138:2088-100.
3. Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008;10:13-27.
4. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007; 50:113-30.
5. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 2010;102:1012-22.
6. Samadder N J, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, Anderson KE, et al. Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women. Am J Gastroenterol 2012; 107:782-9.
7. Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, et al. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut 2012; 61:1299-305.
8. Limburg PJ, Limsui D, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, et al. Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRASmutation status among older women. Cancer Epidemiol Biomarkers Prev 2012;21:681-4.
9. Sanderson P, Stone E, Kim YI, Mathers JC, Kampman E, Downes CS, et al. Folate and colo-rectal cancer risk. Br J Nutr 2007;98:1299-304.
10. Razzak AA, Oxentenko AS, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, et al. Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the iowa women's health study. Nutr Cancer 2012;64: 899-910.
11. Schernhammer ES, Ogino S, Fuchs CS. Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology 2008;135:770-80.
12. Terry MB, Neugut AI, Mansukhani M, Waye J, Harpaz N, Hibshoosh H. Tobacco, alcohol, and p53 overexpression in early colorectal neoplasia. BMC Cancer 2003;3:29.
13. Lopez I, Oliveira PL, Tucci P, Alvarez-Valin F, Coudry AR, Marin M. Different mutation profiles associated to P53 accumulation in colorectal cancer. Gene 2012;499:81-7.
14. Folsom AR, Kaye SA, Prineas RJ, Potter JD, Gapstur SM, Wallace RB. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990;131:794-803.
15. Willett WC, Sampson L, Browne ML, Stampfer MJ, Posner B, Hennekens CH, et al. The use of a self-Administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-99.
16. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117-21.
17. Cheng X, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, et al. Subsitespecific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 2001;92:2547-54.
18. Troisi RJ, Freedman AN, DevesaSS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 1999;85:1670-6.
19. Lee JE, Baba Y, Ng K, Giovannucci E, Fuchs CS, Ogino S, et al. Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies. Cancer Prev Res 2011;4:1808-15.
20. Schernhammer ES, Giovannucci E, Baba Y, Fuchs CS, Ogino S. B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). PloS ONE 2011;6:e21102.
21. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
22. Yu G, Zhu MH, Zhu Z, Ni CR, Zheng JM, Li FM. Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array. Pancreas 2004;28:421-6.
23. Nosho K, Shima K, Kure S, Irahara N, Baba Y, Chen L, et al. JC virus Tantigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. Neoplasia 2009;11:87-95.
24. Curtin K, Slattery ML, Holubkov R, Edwards S, Holden JA, Samowitz WS. p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry. Appl Immunohistochem Mol Morphol 2004;12:380-6.
25. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995;51:524-32.
26. Kanthan R, Senger JL, Kanthan SC. Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int 2012; 2012:597497.